相关实验视频
Updated: Jun 26, 2026

05:41
Non-invasive Assessment of Microvascular and Endothelial Function
Published on: January 29, 2013
阿尔法上腺刺激对区域收缩功能和心肌血流的作用,有或没有缺血症
M I Miyamoto1, H A Rockman, B D Guth
1Seaweed Canyon Laboratory, Department of Medicine, University of California San Diego School of Medicine, La Jolla.
Circulation
|October 11, 1991
概括
在缺血期间对α-上腺素受体的刺激会损害狗的区域收缩功能. 这是由于心脏外壁的血管收缩而发生的,尽管保持了血液流向内层的血流.
科学领域:
- 心血管生理学心血管生理学
- 上腺素受体药理学 上腺素受体药理学
- 心肌缺血研究 肌肉缺血研究
背景情况:
- 阿尔法上腺素受体激活对心肌功能和血液流动的影响仍在争论中.
- 之前的研究已经产生了关于阿尔法上腺素刺激效应的有争议的结果.
研究的目的:
- 研究选择性α1-和α2-上腺素受体刺激对区域收缩功能的影响.
- 评估这些刺激对正常和缺血条件下的跨壁心肌脉血流分布的影响.
主要方法:
- 使用了15只麻醉的开胸狗.
- 选择性α1 (甲胺) 和α2 (BHT 933) 激动剂被输入到左环冠状动脉中.
- 实验在控制和诱导性缺血条件下进行,冠状动脉 perfusion 压力是恒定的.
主要成果:
- 在正常情况下,α-上腺刺激并没有改变收缩功能.
- 在缺血期间,α1和α2刺激显著降低了区域收缩功能 (%WT).
- 这两种受体刺激都导致了对照期间的横静脉血流均下降,但在缺血期间改变了心下/心下血流,增加了该比率.
结论:
- 在缺血期间,心脏外壁层的选择性α1或α2受体介导血管收缩会降低区域收缩功能.
- 这种情况甚至发生在不变的心下内脏血流和改善的心下内脏与心下内脏流量比率的情况下.
- 在这种狗模型中,在心肌缺血期间,α-上腺体血管收缩似乎具有不良影响.
相关概念视频
Anatomy of the Heart
The human heart is made up of three layers of tissue that are surrounded by the pericardium, a membrane that protects and confines the heart. The outermost layer, closest to the pericardium, is the epicardium. The pericardial cavity separates the pericardium from the epicardium. Beneath the epicardium is the myocardium, the middle layer, and the endocardium, the innermost layer. There are four chambers of the heart: the right atrium, the right ventricle, the left atrium, and the left ventricle.
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally, α1-blockers effectively address urinary obstruction...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

